Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program

Guardado en:
Detalles Bibliográficos
Publicado en:BMC Cancer
Autores principales: Adenis, Antoine, de la Fouchardiere, Christelle, Paule, Bernard, Burtin, Pascal, Tougeron, David, Wallet, Jennifer, Dourthe, Louis-Marie, Etienne, Pierre-Luc, Mineur, Laurent, Clisant, Stéphanie, Phelip, Jean-Marc, Kramar, Andrew, Andre, Thierry
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Erratum
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4959046/
https://ncbi.nlm.nih.gov/pubmed/27457763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2559-8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares